Keyphrases
COVID-19
100%
Indonesia
48%
Lopinavir
44%
Surabaya
44%
Drug Combination
44%
In Vitro Study
44%
Hydroxychloroquine
44%
COVID-19 Patients
41%
Azithromycin
38%
SARS-CoV-2 Virus
35%
Mortality Prediction
32%
Doxycycline
30%
Predictive Value
29%
Dual Drug
24%
Mean Arterial Pressure
23%
Intensive Care Unit
22%
Chronic Conditions
22%
Randomized Double-blind
22%
APACHE II
22%
Quick Sequential Organ Failure Assessment (qSOFA)
22%
Acute Physiology
22%
Critically Ill COVID-19 Patients
22%
Clinical Impact
22%
Radiological Parameters
22%
Viral Inactivation
22%
Sequential Organ Failure Assessment
22%
Health Assessment
22%
Early Warning Signals
22%
Moderate COVID-19
22%
Multicenter Clinical Trial
22%
High-flow Nasal Cannula
22%
Acute Respiratory Failure
22%
In-hospital Mortality
22%
COVID-19 Mortality
22%
Lymphocytes
22%
Clinical Laboratory
22%
Referral Hospital
22%
Natural Killer Cells
22%
Hospitalized Patients
22%
COVID-19 Infection
22%
Oxygenation
22%
Antiviral Agents
22%
Antibiotics
22%
Bacterial Infection
22%
Hematopoietic Stem Cells
22%
SF Ratio
16%
Scoring Model
14%
Viral Load
11%
PF Ratio
11%
Scoring System
11%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
46%
Combination Drug
44%
SARS Coronavirus
44%
Hydroxychloroquine
44%
Lopinavir Plus Ritonavir
44%
Azithromycin
38%
Doxycycline
30%
Mixed Infection
22%
Antivirus Agent
22%
Bacterial Infection
22%
Clinical Study
22%
Antibiotics
22%
Prevalence
9%
Favipiravir
8%
Cytotoxicity
8%
Tumor Necrosis Factor
6%
Interleukin 10
6%
Interleukin 6
6%
Pharmacotherapy
5%
Combination Therapy
5%
Clarithromycin
5%
IC50
5%
Medicine and Dentistry
COVID-19
88%
Hemodynamic
22%
Acute Respiratory Failure
22%
Patient Referral
22%
Mixed Infection
22%
COVID-19 Mortality
22%
Nasal Cannula
22%
Lymphocyte
22%
Mean Arterial Pressure
17%
Bacterial Infection
14%
Scoring System
13%
Oxygen Therapy
11%
Breathing Rate
8%
Hypoxemia
5%